Treatment of Metabolic Syndrome in a Community Mental Health Center

Status:	Archived
Conditions:	Psychiatric, Endocrine
Therapuetic Areas:	Endocrinology, Psychiatry / Psychology
Healthy:	No
Age Range:	Any
Updated:	7/1/2011
Start Date:	January 2009
End Date:	September 2012

The purpose of this study is to learn if patients being treated with second generation
antipsychotics and with clinically meaningful elevations/levels in any metabolic syndrome
elements will have better access to medical treatment more quickly if they are randomized to
one of the following conditions: 1) a primary care provider located in the community mental
health center where mental health treatment is provided (IMBED), 2) a medical care manager
to help coordinate treatment with an outside primary care provider (Liaison) or 3) the
standard practice of advising the patient to see a primary care doctor (Treatment as Usual).

Individuals will be identified for participation based upon baseline laboratory values
obtained at the local Community Mental Health Clinic (CMHC) as part of the standard
monitoring procedures for individuals on Second Generation Antipsychotics (SGAs). Following
randomization, a research assistant will be assigned to obtain information on primary care
provider visits, medications and lab tests conducted outside of the CMHC using a signed
release for from the patient. Variables collected include: date and time of all physician
or practitioner visits, type of practitioner, all medication prescriptions, and all
laboratory values and vital signs related to metabolic syndrome parameters. Data will be
put into an access data base for analysis. Data from private pharmacies will be obtained
using a separate signed consent form.

We found this trial at

sites

University of Texas Health Science Center at San Antonio

4502 Medical Drive
San Antonio, Texas 78284

(210) 567-7000